EBMT
Eagle Bancorp Montana, Inc.
EBMT's fundamentals are mixed: revenue grew 9.6%, while earnings per share grew 15%. At 10x earnings, it's trading right at its usual valuation. Analysts expect earnings growth, though they disagree widely on how much.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
EBMT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
EBMT's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like EBMT.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
EBMT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.8x | $15.45 | -25% |
| Forward | 9x | $20.61 | — |
| Fair | 10x | $20.77 | +0.8% |
| Current | 10x | $20.61 | — |
| Expensive | 13x | $24.90 | +21% |
Historical ranges are pointers, not guarantees.
EBMT's PE is in its fair range at 10x. If earnings grow as analysts expect, today's price would be 9.0x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
EBMT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
EBMT has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
EBMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +16% |
| Q3 2026 | $1.98 | +15% |
| Q2 2026 | $2.06 | +29% |
| Q1 2026 | $2.00 | +42% |
| Q4 2025 | $1.90 | +53% |
| Q3 2025 | $1.72 | +61% |
| Q2 2025 | $1.60 | +50% |
| Q1 2025 | $1.41 | +27% |
| Q4 2024 | $1.24 | -3.9% |
EBMT has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
EBMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $25.1M | +7.2% |
| Q2 2026 | $24.2M | +5.2% |
| Q1 2026 | $23.6M | +13% |
| Q4 2025 | $24.3M | +14% |
| Q3 2025 | $23.4M | +13% |
| Q2 2025 | $23M | +15% |
| Q1 2025 | $20.9M | +9.1% |
| Q4 2024 | $21.4M | +1.7% |
EBMT's revenue has grown year over year for eight quarters in a row: $25M last quarter, up 7.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | -5.8 points |
| Q2 2026 | 20% | +2.6 points |
| Q1 2026 | 22% | +3.1 points |
| Q4 2025 | 25% | +7.7 points |
| Q3 2025 | 21% | +5.6 points |
| Q2 2025 | 17% | +6.4 points |
| Q1 2025 | 19% | +6.7 points |
| Q4 2024 | 17% | +8.5 points |
EBMT has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
EBMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.5M | +34% |
| Q2 2026 | -$2.8M | -301% |
| Q1 2026 | -$5.2M | -2079% |
| Q4 2025 | $19.6M | +60% |
| Q3 2025 | $7.1M | +$7.8M |
| Q2 2025 | $1.4M | +121% |
| Q1 2025 | $262K | -89% |
| Q4 2024 | $12.2M | +27% |
EBMT has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
EBMT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +11.5K shares |
| 1 year | +0.6% | +45.4K shares |
| 3 years | +1.1% | +82K shares |
| 5 years | +20% | +1.3M shares |
| Available history | +22% | +1.4M shares |
EBMT has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $410,000 |
| Q3 2025 | — |
| Q2 2025 | $408,000 |
| Q1 2025 | $755,000 |
| Q4 2024 | $419,000 |
EBMT spent $410,000 buying back its own shares over the past year, down 74% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
EBMT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.5x | Healthy |
EBMT's net debt is less than a year of its operating earnings (EBITDA), down from 1.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like EBMT.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
EBMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.8 | Neutral |
| Stochastic | 18.6 | Oversold |
EBMT's weekly RSI is 39 (neutral) and its Stochastic is 19 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
EBMT PE vs Financial Services Sector
| Metric | EBMT | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 20% below |
| PE % | 48 | 63 | 15 pts below |
EBMT is trading at 10x earnings, a 20% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
EBMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.0 | 1.9% below |
| 20 week MA | $22.3 | 7.4% below |
| 50 week MA | $21.8 | 5.4% below |
| 100 week MA | $19.2 | 7.5% above |
| 200 week MA | $16.6 | 24% above |
EBMT has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
EBMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.1 | $21.9 | +3.8% |
| 2021 | $21.9 | $22.9 | +4.7% |
| 2022 | $22.9 | $16.2 | -29% |
| 2023 | $16.2 | $15.8 | -2.4% |
| 2024 | $15.8 | $15.3 | -3.4% |
| 2025 | $15.3 | $19.8 | +30% |
| 2026 YTD | $19.8 | $20.6 | +4.2% |
EBMT has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.